MedTrace Logo

OCT Evaluation of Early Healing of EPC Capturing (GENOUS) Stent (EGO Study)

NCT01272895 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 53

Last updated 2013-02-28

No results posted yet for this study

Summary

All patients who have received GENOUS stent implantation at Queen Mary Hospital for treatment of ischemic heart disease are eligible for this study. Those with clinical indications to undergo restudy coronary angiogram or staged procedure PCI will be primarily recruited into this study.

Optical coherence tomography (OCT) will be performed early after stent implantation to evaluate vascular healing response and neointimal coverage.

Conditions

Interventions

DEVICE

Coronary Intervention (GENOUS stent)

GENOUS stent (Coronary Intervention)

Sponsors & Collaborators

  • Prof. Stephen Lee

    lead OTHER

Principal Investigators

  • Stephen WL Lee, MD FRCP FACC · Queen Mary Hospital, The University of Hong Kong

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-06-30
Primary Completion
2011-08-31
Completion
2011-08-31

Countries

  • Hong Kong

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01272895 on ClinicalTrials.gov